Drug Profile
Carvedilol controlled release - GSK
Alternative Names: Carvedilol phosphate; Coreg CR; Coreg CR Micropump; COREG MR; SKF 105517-DLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator Roche
- Developer Columbia University; GSK
- Class Antihypertensives; Carbazoles; Ethanolamines; Heart failure therapies; Ischaemic heart disorder therapies; Phenyl ethers; Propanolamines; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor antagonists; Beta-adrenergic receptor antagonists; Calcium channel antagonists; P-glycoprotein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Heart failure; Hypertension; Left ventricular dysfunction
- Discontinued Epilepsy
Most Recent Events
- 16 Apr 2021 Discontinued - Phase-III for Hypertension in Canada (PO)
- 16 Apr 2021 Discontinued - Phase-III for Hypertension in Puerto Rico (PO)
- 03 Jan 2017 Flamel Technologies completed its cross-border merger with Avadel Pharmaceuticals and is now called Avadel Pharmaceuticals